Literature DB >> 15762251

Effective and accurate screening for diabetic retinopathy using a 60 degree mydriatic fundus camera.

T R Carmichael1, G I Carp, N D Welsh, W J Kalk.   

Abstract

UNLABELLED: OBJECTIVES. To establish whether an experienced endocrinologist could screen accurately for diabetic retinopathy using mydriatic 60 degree fundus photographs compared with a reference standard, viz. the combined highest scores of two experienced ophthalmologists.
DESIGN: Retrospective review of 60 degree colour transparency photographs taken over a 6-year period. Retinopathy was graded in a standardised way.
SETTING: Patients attending the diabetic clinic at Johannesburg Hospital, South Africa.
SUBJECTS: Fifteen hundred and seventeen patients (2446 eyes) formed the basis for the study. Patients were included if there was more than 50% readability of the fundus photographs. OUTCOME MEASURES: Outcome measures were prevalence of any retinopathy and presence of referable (severe) retinopathy. Interobserver agreement was measured using the kappa statistic, and sensitivity and specificity of the screener were evaluated.
RESULTS: The prevalence of retinopathy at the clinic was approximately 30%, but only about 12% was severe enough to warrant referral to the ophthalmology outpatient department. The endocrinologist was very accurate in determining cases requiring referral; there was 97% agreement with the reference standard, viz. the combined highest score of two experienced ophthalmologists (gold standard). Correlation on the determination of any retinopathy was less accurate (80% agreement), mostly owing to the endocrinologist reporting more isolated microaneurysms than the ophthalmologists. The screening method used gave a sensitivity of 83% and specificity of 99% which are within recommended standards.
CONCLUSIONS: The screening strategy using a mydriatic fundus camera at the diabetic clinic was found to be effective and accurate and greatly reduced the number of possible referrals to the ophthalmology outpatient department.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762251

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  Early local functional changes in the human diabetic retina: a global flash multifocal electroretinogram study.

Authors:  Jenny C Y Lung; Peter G Swann; Henry H L Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-12       Impact factor: 3.117

2.  No loss of chance of diabetic retinopathy screening by endocrinologists with a digital fundus camera.

Authors:  Natacha Germain; Bodgan Galusca; Nilanjana Deb-Joardar; Luc Millot; Pierre Manoli; Gilles Thuret; Philippe Gain; Bruno Estour
Journal:  Diabetes Care       Date:  2011-01-25       Impact factor: 19.112

3.  Expression of the Wnt signaling system in central nervous system axon guidance and regeneration.

Authors:  Edmund R Hollis; Yimin Zou
Journal:  Front Mol Neurosci       Date:  2012-02-02       Impact factor: 5.639

Review 4.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

5.  Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients Attending the Diabetic Clinic of the University of Gondar Hospital, Northwest Ethiopia.

Authors:  Asamere Tsegaw; Shitaye Alemu; Abere Dessie; Christopher C Patterson; Eldryd H O Parry; David I W Phillips; Elisabeth R Trimble
Journal:  J Ophthalmol       Date:  2021-03-31       Impact factor: 1.909

6.  Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa.

Authors:  Rebecca L Thomas; Larry Distiller; Stephen D Luzio; Sharmistha Roy Chowdhury; Vanessa J Melville; Brian Kramer; David R Owens
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

Review 7.  Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic.

Authors:  Philip I Burgess; Gerald Msukwa; Nicholas A V Beare
Journal:  BMC Med       Date:  2013-07-02       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.